Silvio Furino, President of AXA Diagnostics, said, “We are excited about our new relationship with Hemagen Diagnostics. We expect to put particular emphasis on Hemagen’s autoimmune immunofluorescence assays (IFA) and infectious disease IFA kits that are marketed under the Virgo® trade name. The Virgo name is well-known throughout the world and we are pleased to be able to add these specialized diagnostic assays to our expanding catalog of tests that we market to our customers.”

AXA Diagnostics is a private company located in Pomezia, Italy that markets specialized diagnostic tests. AXA Diagnostics sells over 300 diagnostic products on a direct basis in Italy and through a network of distributors in Europe. AXA Diagnostics has obtained certification for the management of its quality system according to the requirements of UNI EN ISO 13485:2004. More information on AXA Diagnostics is available at www.axadiagnostics.com.

About Hemagen Diagnostics

Hemagen Diagnostics, Inc. (OTC:HMGN) develops, manufactures and markets more than 85 FDA-cleared proprietary test kits used to aid in the diagnosis of certain autoimmune and infectious diseases. Hemagen's products are used in many of the largest laboratories, hospitals and blood banks around the world.

Various statements in this release concerning comments regarding future expectations, plans and prospects and constitute forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Any forward-looking statements represent AXA Diagnostics’ views only as of the date of this release and should not be relied upon as representing its views as of any subsequent date. AXA Diagnostics does not assume any obligation to update any forward-looking statements unless required by law.

 

AXA Diagnostics Srl Company Contact:

AXA Diagnostics Srl

Via Campobello, 1

00040 Pomezia – ROMA (Italy)

Telephone: 39 06 912 511 79

Email: info@axadiagnostics.com